EP-1270: SBRT for liver metastases from low grade neuroendocrine tumors
نویسندگان
چکیده
منابع مشابه
Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors
Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are rare, and there is no report specifically dealing with patients of liver metastases from G3 GEP NETs.From January 2004 to January 2014, 36 conservative patients with G3 GEP NET liver metastases were retrospectively identified from 3 hepatobiliary centers in China. The clinical features and treatment outcomes were analyze...
متن کاملLow Grade Neuroendocrine Tumors of the Lung
The lung is the second most common site of neuroendocrine tumors (NETs). Typical and atypical carcinoids are low-grade NETs of the lung. They present a favorable prognosis comported to the more common high-grade NETs. The low- and high-grade NETs require different treatment strategies; effective management of these tumors is essential to prolong survival and to manage the symptoms in patients w...
متن کاملMR-imaging characteristics and post-therapeutic morphologic changes in liver metastases from neuroendocrine tumors
Introduction: Liver metastases of neuroendocrine tumors (NET) show MRI-characteristics, which differ from most other liver metastases; i.e. they are hypervascular in the hepatic arterial dominant phase (1;2). The response of the metastases to treatment is not sufficiently reflected by the RECIST criteria. However, metastases of NET rather show characteristic changes to treatment, like central n...
متن کاملLaser thermal ablation in multimodality treatment of liver metastases from neuroendocrine tumors
17-20 October 2014 Paris, France 62th Annual Meeting JFR Journées Françaises de Radiologie http://jfr.radiologie.fr/ Liver metastases (LM) from neuroendocrine tumors (NET) occur with variable frequency depending on the primary disease, ranging from 5-10% for carcinoid to 75% for glucagonoma1. LM have a major impact on survival, and the relatively indolent nature of well-differentiated NET and t...
متن کاملPerfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment.
AIM To evaluate modifications of perfusional parameters assessed by perfusion computed tomography (P-CT) of liver metastases (LM) from pancreatic neuroendocrine tumors (PanNETs) during everolimus treatment. PATIENTS AND METHODS All patients with LMs from G1-2 PanNETs undergoing everolimus treatment between January 2013 and January 2015 were prospectively evaluated with P-CT at baseline, and a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2016
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(16)32520-8